Total Clarity Wealth Management, Inc. Oncternal Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$0.7 - $1.56 $4,900 - $10,920	7,000 New	7,000 $8,000
Q1 2022 Apr 29, 2022	SELL	$1.37 - $2.43 $27,476 - $48,736	-20,056 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$2.27 - $4.39 $14,468 - $27,981	-6,374 Reduced 24.12%	20,056 $46,000
Q3 2021 Oct 21, 2021	BUY	$3.37 - $4.76 $89,069 - $125,806	26,430 New	26,430 $110,000
Q2 2021 Jul 26, 2021	SELL	$4.75 - $9.39 $147,558 - $291,700	-31,065 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$4.59 - $9.04 $142,588 - $280,827	31,065 New	31,065 $258,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.